Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 2Other neoplasm 1

Conditions

Precancerous Conditions 5Tongue Neoplasms 1Rectal Neoplasms 1Oropharyngeal Neoplasms 1Nasopharyngeal Neoplasms 1Mouth Neoplasms 1Leukoplakia, Oral 1Keratosis, Actinic 1Hypopharyngeal Neoplasms 1Head and Neck Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Adenomatous Polyposis Coli 1

Interventions

Aminolevulinic Acid 4tirbanibulin 1perillyl alcohol 1Triamcinolone 1Microarray Analysis 1Laser Therapy 1Imiquimod 1Excipients 1Eflornithine 1Deoxyribonuclease (Pyrimidine Dimer) 1Celecoxib 1Biopsy 1BF-200 ALA 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Keratosis, Actinic × Celecoxib × Other neoplasm × Clear all
NCT00027976 2013-08-05

Celecoxib in Preventing Skin Cancer in Patients With Actinic Keratoses

University of Alabama at Birmingham

Phase 2/3 Withdrawn
DermatologicOther neoplasm

Precancerous Conditions, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡